The Complete Metabolism Guide
The Hidden Engine Running Every Biological Process in Your Body — And How the Modern World Has Broken It
Very second of every minute of every hour of your life, your body is performing an act of extraordinary biological complexity that you never think about, never instruct, and never consciously experience.
It is taking the food you ate, the air you breathed, and the water you drank, and converting them into the energy that powers every heartbeat, every thought, every immune response, every hormonal signal, every cellular repair operation, and every moment of conscious experience that constitutes your life.
This process is your metabolism. And for most people alive in the modern world, it is broken.
Not catastrophically, not all at once, and not in a way that announces itself with obvious symptoms until the damage has accumulated over years or decades to the point where the medical system has a name for what has gone wrong. Metabolic dysfunction is the slow, cumulative, largely invisible deterioration of the body’s most fundamental biological process, driven by the accumulated daily insults of a modern lifestyle that is so thoroughly incompatible with the metabolic requirements of the human body that the consequences of the incompatibility now define the leading causes of death, disability, and suffering in every developed country on earth.
The metabolic syndrome epidemic, with its constellation of abdominal obesity, insulin resistance, elevated triglycerides, low HDL cholesterol, and hypertension, now affects an estimated 25% of the global adult population and over 40% of Americans over the age of 40. Type 2 diabetes, the most advanced clinical expression of metabolic dysfunction, affects 537 million people worldwide with projections suggesting 700 million by 2045. Obesity, the most visible metabolic consequence of the modern environment, affects approximately 650 million adults globally. And the cardiovascular disease, the non-alcoholic fatty liver disease, the polycystic ovarian syndrome, the Alzheimer’s disease, and the cancer that metabolic dysfunction drives collectively represent the leading causes of premature death in every country that has adopted the Western lifestyle.
These are not inevitable biological outcomes. They are not genetic misfortunes distributed randomly across the population. They are the predictable, documentable, mechanistically coherent consequences of the most dramatic dismantling of the human metabolic environment in the history of our species, conducted over the last century through the industrialisation of the food supply, the creation of the sedentary lifestyle, the disruption of the circadian clock by artificial light, the systematic depletion of the nutrients that metabolic enzymes depend on, and the chronic stress that the modern world generates as an unavoidable feature of daily life.
This guide is the complete account of what metabolism actually is, what is breaking it in the modern world, what diseases it drives when broken, what specific, evidence-based, ancestrally grounded interventions restore it, and why the system responsible for managing its consequences has such a profound interest in never addressing its root causes.
What Is Metabolism?
Metabolism is one of the most used and most misunderstood words in health and wellness. In popular usage it typically refers to the speed at which the body burns calories, and conversations about metabolism are usually framed around whether someone has a fast or slow metabolism as though it were a fixed personal characteristic like height or eye colour. This understanding is not merely incomplete. It is so reductive as to be almost meaningless as a foundation for understanding metabolic health and its pathological consequences.
Metabolism, in its complete biological meaning, is the totality of all the chemical reactions occurring in every cell of every tissue of every organ in the body at every moment of every day. It encompasses every reaction that builds biological molecules, anabolism, and every reaction that breaks them down, catabolism. It includes every reaction that produces energy and every reaction that consumes it. It includes the synthesis of every protein, every hormone, every neurotransmitter, every structural molecule, and every signalling compound the body uses. It is not a single process. It is the sum of all biological processes, and its coordination across 37 trillion cells in an organism of extraordinary complexity is one of the most remarkable feats of biological organisation in the natural world.
TP and How It Is Made
The fundamental currency of cellular metabolism is adenosine triphosphate, ATP, the molecule that stores and transfers the chemical energy that powers every energy-requiring biological process. The synthesis and utilisation of ATP is the metabolic activity that most directly determines energy levels, physical capacity, cognitive function, and the ability of cells to perform their specific biological work.
ATP is produced through several interconnected metabolic pathways whose relative contributions depend on the availability of substrates, the oxygen status of the tissue, and the energy demands being placed on the cell at any given moment. The primary ATP-producing pathway is oxidative phosphorylation, the electron transport chain of the mitochondria, where the electrons extracted from glucose through glycolysis and from fatty acids through beta-oxidation are used to drive the synthesis of ATP with extraordinary efficiency, producing up to 36 to 38 molecules of ATP per molecule of glucose completely oxidised.
The mitochondria are therefore the metabolic engines of every cell, and their health, their number, their structural integrity, and the efficiency of their electron transport chains are the primary determinants of metabolic capacity at the cellular level. Mitochondrial dysfunction, produced by the oxidative stress of poor diet, the sedentary lifestyle that fails to provide the exercise stimulus for mitochondrial biogenesis, the CoQ10 depletion of statin medication, the chronic inflammation that damages mitochondrial membranes, and the environmental toxins that impair electron transport chain components, is now understood as a central mechanism of virtually every major chronic disease, from cardiovascular disease to neurodegeneration to cancer.
The Hormonal Orchestration of Metabolism
While every cell conducts its own metabolic processes, the coordination of metabolism across the entire organism is achieved through an extraordinarily complex system of hormonal signalling that regulates fuel selection, energy storage, energy mobilisation, and the metabolic rate of every tissue in the body.
Insulin is the master anabolic hormone of metabolism, secreted by the beta cells of the pancreatic islets of Langerhans in response to elevated blood glucose following a meal. Its primary metabolic actions are the promotion of glucose uptake into muscle and adipose tissue, the promotion of glycogen synthesis in the liver and muscle, the promotion of fatty acid synthesis and triglyceride storage in adipose tissue, and the inhibition of gluconeogenesis, the liver’s production of glucose from non-carbohydrate precursors. Insulin is the body’s primary signal that energy is abundant and that it should be stored rather than mobilised.
Glucagon, secreted by the alpha cells of the pancreatic islets in response to low blood glucose, is insulin’s functional antagonist. It promotes glycogen breakdown in the liver, gluconeogenesis from amino acids and glycerol, and the mobilisation of fatty acids from adipose tissue for energy production. Glucagon is the body’s primary signal that energy is scarce and that stored reserves should be mobilised.
The ratio between insulin and glucagon at any moment determines the overall metabolic direction of the entire body: toward anabolism and energy storage when insulin dominates, and toward catabolism and energy mobilisation when glucagon dominates. The disruption of this ratio by the chronic hyperinsulinaemia of the modern high-carbohydrate, high-glycaemic dietary pattern is the central mechanism of metabolic syndrome and the direct driver of the insulin resistance, the abdominal obesity, the dyslipidaemia, and the cardiovascular risk that characterise it.
Thyroid hormones, T3 and T4, are the primary regulators of the basal metabolic rate, the speed at which every cell performs its metabolic work at rest. T3, the active thyroid hormone, directly regulates the expression of the genes encoding the proteins of the electron transport chain, the mitochondrial ATP synthesis machinery, and the uncoupling proteins that determine how much of the energy released by fuel oxidation is captured as ATP versus released as heat. Thyroid hormone determines how fast the metabolic engine runs, and its deficiency in the epidemic of hypothyroidism documented in the thyroid article produces the metabolic slowdown, the weight gain, the fatigue, and the cognitive impairment that characterise the condition.
Cortisol, the glucocorticoid produced by the adrenal cortex in response to stress and to the circadian clock, has profound metabolic effects that are appropriate in the acute context for which it was designed and deeply damaging in the chronic context that the modern world has created. Acute cortisol promotes gluconeogenesis to provide fuel for the fight-or-flight response, promotes the breakdown of muscle protein for gluconeogenesis substrate, and promotes the mobilisation of adipose tissue fatty acids for energy. These are appropriate acute adaptations that provide the energy required for survival-level physical performance. In the chronically elevated cortisol state of modern chronic stress, these actions produce the muscle wasting, the insulin resistance, the abdominal fat deposition, and the metabolic dysfunction of the chronically stressed modern body.
Leptin and ghrelin are the hormones most directly responsible for the regulation of appetite and energy intake that, in a healthy metabolic environment, maintain the body weight setpoint at the appropriate level for the individual. Leptin, produced by adipose cells in proportion to their fat content, signals the hypothalamus that energy stores are adequate and that appetite should be suppressed. Ghrelin, produced by the stomach, signals hunger and promotes food seeking. In the leptin-resistant state that obesity, chronic inflammation, and sleep deprivation produce, the satiety signal from leptin is no longer received by the hypothalamus, producing the persistent hunger and reduced satiety that make weight management so much harder than simple calorie counting acknowledges.
The Microbiome-Metabolism Connection
The gut microbiome is a metabolic organ in its own right, performing metabolic functions that the human genome alone could never accomplish and that profoundly influence the host’s metabolic status. The gut bacteria ferment the dietary fibre that human digestive enzymes cannot break down, producing the short-chain fatty acids butyrate, propionate, and acetate that are the primary fuel of colonocytes, regulate hepatic lipid metabolism, improve insulin sensitivity in peripheral tissues, and influence the appetite-regulating hormones GLP-1 and PYY that signal satiety to the hypothalamus.
Research published in Nature demonstrated that transplanting the gut microbiome from obese mice into germ-free lean mice caused the lean mice to gain significant body fat without any change in caloric intake, definitively demonstrating that the gut microbiome is a direct determinant of metabolic function and fat storage independent of diet. The gut microbiome of metabolically healthy individuals consistently shows greater diversity, greater abundance of the short-chain fatty acid-producing Firmicutes species, and lower abundance of the inflammatory Proteobacteria species than the microbiome of metabolically compromised individuals, and research has shown that restoring microbiome diversity through dietary intervention produces measurable improvements in insulin sensitivity and metabolic markers.
The Diseases Connected to Metabolic Dysfunction
Metabolic dysfunction does not produce a single disease. It produces a cascade of pathological consequences that ripple outward from the central metabolic disturbance of insulin resistance and chronic inflammation to affect virtually every organ system in the body, manifesting as conditions that receive separate diagnoses, separate specialists, and separate pharmaceutical management without anyone connecting them back to their shared metabolic root.
Type 2 Diabetes — The End Stage of Metabolic Dysfunction
Type 2 diabetes is the clinical endpoint of the insulin resistance progression that begins years to decades before the diagnostic blood glucose threshold is crossed. In the early stages of insulin resistance, the pancreatic beta cells compensate for the reduced insulin sensitivity of peripheral tissues by producing more insulin, maintaining normal blood glucose at the cost of chronic hyperinsulinaemia. As insulin resistance deepens and beta cell function progressively declines from the exhaustion of sustained overproduction and the glucotoxicity and lipotoxicity of the metabolic environment, the compensatory hyperinsulinaemia is no longer sufficient to maintain blood glucose within the normal range, and the elevated fasting and postprandial glucose of type 2 diabetes becomes apparent.
The downstream consequences of chronic hyperglycaemia and the chronic inflammation that accompanies insulin resistance produce the diabetic complications that are the primary determinants of morbidity and mortality in type 2 diabetes: diabetic nephropathy through the glomerular damage of chronic hyperglycaemia, diabetic retinopathy through the microvascular damage to the retinal blood vessels, diabetic neuropathy through the oxidative damage to peripheral nerves, and the dramatically elevated cardiovascular risk through the endothelial dysfunction, the dyslipidaemia, and the prothrombotic state that the metabolic syndrome produces. What is rarely communicated to patients receiving a type 2 diabetes diagnosis is that the condition is reversible in the majority of cases through dietary and lifestyle interventions that address its root causes, a fact documented in multiple clinical trials and virtually never communicated in the clinical encounter that generates the first metformin prescription.
Cardiovascular Disease — Metabolism’s Most Lethal Consequence
The connection between metabolic dysfunction and cardiovascular disease is the most consequential and most extensively documented relationship in all of chronic disease epidemiology. The dyslipidaemia of metabolic syndrome, characterised by elevated triglycerides, low HDL cholesterol, and the small dense LDL particles that are most atherogenic, creates the lipid environment that promotes arterial plaque formation. The endothelial dysfunction of insulin resistance impairs the nitric oxide production that maintains arterial health. The chronic inflammation of metabolic syndrome drives the atherosclerotic process that produces the arterial narrowing and plaque instability that causes heart attacks and strokes. And the hypertension that is one of the five defining criteria of metabolic syndrome adds the haemodynamic stress that accelerates arterial damage.
Research published in the Lancet found that metabolic syndrome independently doubled the risk of cardiovascular disease and increased the risk of cardiovascular mortality by 1.5 times, effects that were present independent of and additive to the individual cardiovascular risk factors that comprise the syndrome. The vast majority of cardiovascular events occur in people with metabolic syndrome, and the pharmaceutical management of individual metabolic syndrome components, statins for the dyslipidaemia, antihypertensives for the blood pressure, and metformin for the glucose, manages the individual risk factors while leaving the metabolic dysfunction that generates all of them largely unaddressed.
Non-Alcoholic Fatty Liver Disease — The Silent Metabolic Epidemic
Non-alcoholic fatty liver disease, the accumulation of fat in liver cells in the absence of significant alcohol consumption, is now the most common liver disease in the world, affecting an estimated 25% of the global population and up to 30 to 40% of adults in Western countries. It is the hepatic manifestation of metabolic syndrome, driven by the same insulin resistance and dyslipidaemia that produce cardiovascular disease and type 2 diabetes, and it exists on a spectrum from simple steatosis, benign fat accumulation, through non-alcoholic steatohepatitis with active inflammation and liver cell damage, to fibrosis and ultimately cirrhosis and liver failure.
The primary dietary driver of non-alcoholic fatty liver disease is fructose, the sweetening compound abundant in high-fructose corn syrup and table sugar, whose hepatic metabolism bypasses the regulatory steps of glycolysis and directly drives de novo lipogenesis, the conversion of fructose to fat in the liver, at rates that overwhelm the liver’s capacity to export the resulting lipids as VLDL and that result in their accumulation as intrahepatic triglycerides. Research published in the Journal of Hepatology found that fructose consumption was the single strongest dietary predictor of non-alcoholic fatty liver disease severity, more predictive than total calorie intake or total fat intake.
Polycystic Ovarian Syndrome — Metabolic Dysfunction in the Female Endocrine System
Polycystic ovarian syndrome, the most common endocrine disorder in women of reproductive age affecting 8 to 13% of this population, is fundamentally a metabolic and insulin resistance condition whose reproductive and hormonal consequences are the expressions through which it is most commonly recognised and managed, while its metabolic root is addressed either inadequately or not at all.
The insulin resistance that characterises PCOS directly drives the androgen excess that produces the irregular periods, the acne, the hirsutism, and the polycystic ovarian morphology that define the condition. Elevated insulin stimulates the ovarian theca cells to produce excess androgens and impairs the hepatic production of sex hormone-binding globulin, increasing the proportion of free, biologically active androgens circulating in the blood. The management of PCOS with the oral contraceptive pill suppresses the ovarian androgen production and regulates the menstrual cycle without addressing the insulin resistance driving both, producing a management that is effective for as long as the pill is taken and that leaves the underlying metabolic dysfunction to continue driving the long-term health consequences of PCOS including elevated type 2 diabetes risk, elevated cardiovascular risk, and elevated endometrial cancer risk.
Cancer — The Metabolic Disease Nobody Discusses
The metabolic theory of cancer, first articulated by Otto Warburg in 1924 and subsequently elaborated by researchers including Thomas Seyfried at Boston College, proposes that cancer is fundamentally a metabolic disease driven by mitochondrial dysfunction that forces cancer cells to rely on the inefficient but rapid glucose fermentation of the Warburg effect for their energy production, and that the metabolic environment created by insulin resistance, chronic inflammation, hyperglycaemia, and mitochondrial dysfunction is the permissive environment in which cancer cells arise, survive, and proliferate.
Research has found consistent associations between metabolic syndrome components and elevated cancer risk across multiple cancer types. Obesity is an established risk factor for at least 13 cancer types. Hyperinsulinaemia promotes cancer cell proliferation through IGF-1 receptor activation and mTOR pathway stimulation. Chronic inflammation creates the immunosuppressive microenvironment that allows cancer cells to evade immune surveillance. And the dyslipidaemia of metabolic syndrome provides the lipid substrate for the membrane synthesis and signalling that rapidly dividing cancer cells require.
The therapeutic implications of the metabolic cancer theory are direct and accessible. The ketogenic diet, which starves cancer cells of their primary fuel glucose while providing ketones that normal cells but not most cancer cells can efficiently metabolise, is among the most compelling metabolic interventions in cancer care and among the most consistently underinvestigated relative to its evidence base and its safety profile.
What Affects Your Metabolism, The Modern Metabolic Disruptors
Understanding the specific factors that impair metabolic function in the modern world is the prerequisite for the healing protocol in the next chapter. Every factor listed here is modifiable, and every modification produces measurable improvements in metabolic markers.
Diet — The Primary Metabolic Disruptor
The modern Western diet is the single most powerful driver of metabolic dysfunction in the modern world, operating through multiple simultaneous mechanisms that collectively produce the insulin resistance, the mitochondrial dysfunction, the chronic inflammation, and the microbiome disruption that underlie every manifestation of the metabolic syndrome.
Refined carbohydrates and added sugars produce the chronic blood glucose elevation and compensatory hyperinsulinaemia that are the primary drivers of insulin resistance through the progressive downregulation of insulin receptors and the impairment of post-receptor insulin signalling in muscle, liver, and adipose tissue. The specific contribution of fructose from high-fructose corn syrup and table sugar to the hepatic de novo lipogenesis that produces non-alcoholic fatty liver disease, the dyslipidaemia of metabolic syndrome, and the hepatic insulin resistance that impairs the liver’s role in glucose homeostasis makes sugar the single most metabolically damaging dietary component of the modern food supply.
Industrial seed oils produce metabolic disruption through their extraordinary omega-6 content that drives the chronic systemic inflammation impairing insulin signalling, their tendency to oxidise into aldehydes and other reactive compounds that damage mitochondrial membranes and impair electron transport chain function, and their interference with the elongation and desaturation of omega-3 fatty acids that are required for the anti-inflammatory lipid mediators whose deficiency perpetuates chronic metabolic inflammation.
Sedentary Lifestyle — The Movement Debt
Physical movement is one of the most powerful metabolic medicines available to any human being, and the progressive elimination of daily movement from modern life is one of the most consequential metabolic disruptors of the modern era. Skeletal muscle is the largest metabolically active tissue in the body and the primary site of insulin-stimulated glucose disposal, and its capacity to take up and utilise glucose, the primary determinant of whole-body insulin sensitivity, is directly maintained by regular physical activity and directly impaired by sedentary behaviour.
The loss of insulin-stimulated glucose uptake in sedentary muscle is one of the primary drivers of the hyperglycaemia and compensatory hyperinsulinaemia that initiate the metabolic syndrome cascade. Research has found that a single day of complete bed rest produces measurable insulin resistance in healthy individuals, and that prolonged sedentary behaviour in otherwise active people produces metabolic consequences that their regular exercise sessions do not fully compensate for, reflecting the specific metabolic importance of the low-intensity, continuous movement of ancestral life that cannot be replicated by an hour at the gym followed by eight hours of sitting.
Sleep Deprivation and Circadian Disruption
Sleep deprivation produces insulin resistance through multiple simultaneous mechanisms that make chronic short sleep one of the most powerful metabolic disruptors of modern life. A study published in the Annals of Internal Medicine found that restricting healthy volunteers to 5.5 hours of sleep per night for two weeks produced a 40% reduction in insulin sensitivity compared to the same volunteers sleeping 8.5 hours, an impairment comparable to that produced by months of a poor diet. Research published in Diabetes Care found that even a single night of partial sleep restriction produced significant insulin resistance in healthy young adults.
The mechanisms involve the elevation of the counter-regulatory hormones cortisol and growth hormone that impair insulin action, the increase in sympathetic nervous system activity that reduces peripheral glucose uptake, the elevation of inflammatory cytokines that directly impair insulin receptor signalling, and the disruption of the appetite-regulating hormones leptin and ghrelin that increases hunger and promotes overconsumption of the high-calorie foods most damaging to metabolic function.
Chronic Stress and Cortisol
Chronic psychological stress is a direct metabolic disruptor through its activation of the hypothalamic-pituitary-adrenal axis and the sustained cortisol elevation that results. Cortisol promotes hepatic gluconeogenesis, increases blood glucose, drives peripheral insulin resistance, promotes the preferential deposition of fat in the visceral adipose tissue that is most metabolically active and most inflammatory, and impairs the pancreatic beta cell function whose deterioration is the final step in the development of type 2 diabetes.
The relationship between stress and metabolic dysfunction is bidirectional and self-reinforcing. Chronic stress drives metabolic dysfunction. Metabolic dysfunction impairs the physiological stress response. And the social, financial, and health consequences of metabolic disease generate the additional chronic psychological stress that perpetuates the metabolic disruption driving them. Breaking this cycle requires simultaneous attention to the metabolic and the psychological dimensions of the condition, a complexity that the fifteen-minute appointment is structurally incapable of addressing.
Environmental Endocrine Disruptors
The endocrine disrupting chemicals that permeate the modern environment, including the BPA and phthalates of plastic food packaging, the pesticide residues of conventionally grown produce, the synthetic oestrogens of tap water, the PFAS compounds of non-stick cookware, and the industrial chemicals of personal care products, are recognised metabolic disruptors whose effects on insulin signalling, thyroid function, adipogenesis, and the hormonal environment that coordinates metabolic function deserve far more attention in the metabolic health conversation than they currently receive.
Research has found associations between urinary BPA concentrations and elevated rates of type 2 diabetes, obesity, and metabolic syndrome in large epidemiological studies. Phthalate exposure has been associated with impaired thyroid function, insulin resistance, and abdominal obesity. And the PFAS compounds, the forever chemicals present in the blood of virtually every person tested in developed countries, have been associated with impaired thyroid function, elevated cholesterol, and insulin resistance in multiple research studies. These compounds are entering the body through food packaging, cookware, tap water, and personal care products and are disrupting the hormonal and metabolic environment from the inside in ways that dietary intervention alone cannot fully address.
Nutritional Deficiencies
The specific micronutrient deficiencies most directly associated with metabolic dysfunction represent the nutritional dimension of the metabolic crisis that the supplement industry addresses in fragments and the food industry produces through the mineral depletion and processing of the modern food supply.
Magnesium deficiency impairs the insulin receptor tyrosine kinase activity that initiates insulin signalling, directly producing insulin resistance independent of any other metabolic factor. Research has found that each unit increase in serum magnesium is associated with a 15% reduction in type 2 diabetes risk, and that magnesium supplementation produces significant improvements in insulin sensitivity in magnesium-deficient individuals. Chromium deficiency impairs the glucose tolerance factor that potentiates insulin action at the cellular level. Zinc deficiency impairs insulin synthesis, storage, and secretion by pancreatic beta cells. Vitamin D deficiency impairs the insulin secretory response to glucose challenge and the insulin sensitivity of peripheral tissues. And the B vitamin deficiencies produced by the processed food diet and the medications that deplete them impair the cofactor function required for every step of carbohydrate metabolism and mitochondrial energy production.
The Complete Ancestral and Holistic Protocol for Metabolic Healing
This is the longest and most important chapter in this guide because the metabolic healing protocol is comprehensive, multi-layered, and requires the simultaneous addressing of every driver of metabolic dysfunction to produce the genuine, durable restoration of metabolic health that neither pharmaceutical intervention nor single dietary change achieves alone. Every intervention here has documented mechanisms of action and evidence of metabolic benefit. Used together, they produce changes in metabolic markers that most practitioners consider remarkable and that are, from the perspective of the ancestral and holistic approach, simply the predictable outcome of giving the body’s metabolic machinery the conditions it was always designed to operate within.
— Join 262+ paid and 5800+ free subscribes in our fight to become more healthy, more vital, and more big Pharma independent every single day —
Keep reading with a 7-day free trial
Subscribe to Ancestral Healing to keep reading this post and get 7 days of free access to the full post archives.